Ceftobiprole

Ceftobiprole is a medication used to treat schizophrenia and bipolar I disorder. It is a combination of the antipsychotic drug quetiapine and the mood stabilizer valproic acid. The drug works by affecting certain chemicals in the brain that are involved in mood and behavior.

Ceftobiprole was approved by the U.S. Food and Drug Administration (FDA) in 2018. It is available in tablet form and is typically taken once daily. The medication is indicated for the treatment of schizophrenia in adults and adolescents aged 13 years and older, as well as for the acute manic or mixed episodes associated with bipolar I disorder in adults.

Common side effects of ceftobiprole include weight gain, dizziness, and somnolence. Serious side effects may include increased risk of suicidal thoughts or behavior, and an increased risk of developing diabetes. It is important to discuss any side effects with a healthcare provider.

Ceftobiprole should be used with caution in patients with a history of seizures, liver disease, or diabetes. The medication may interact with other drugs, so it is important to inform healthcare providers about all medications being taken. Pregnant or breastfeeding women should not use ceftobiprole unless directed by a healthcare provider.